GlassScriptPhysician profile
Grady D Alsabrook
NPI 1699898643
$9,011.82
in general payments reported to CMS, 2019-2025
27 companies · $1,119 in 2025
The $1,119 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $392 · 2020: $4,628 · 2021: $473 · 2022: $1,021 · 2023: $1,182 · 2024: $197 · 2025: $1,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,899 · Consulting Fee: $600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,898.76 |
| Consulting Fee | $600.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $5,355.93 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Philips North America LLC | $702.48 | 2019-2025 | Igt Devices Undivided, (Am7) Stellarex |
| Cvrx, INC. | $512.28 | 2023-2024 | Barostim Neo System |
| Shockwave Medical, INC | $407.56 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $359.73 | 2022-2025 | Endocross Device, Torus Stent Graft System, Afx2 Bifurcated Endograft System |
| Lemaitre Vascular, INC. | $332.31 | 2019-2025 | Artegraft Vascular Graft, Restoreflow, Hydro Lemaitre Valvulotome |
| W. L. Gore & Associates, INC. | $280.03 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Endoprosthesis |
| Cardiva Medical, INC. | $191.61 | 2021-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Shape Memory Medical INC. | $169.66 | 2022-2025 | Impede Embolization Plug |
| Medtronic Vascular, INC. | $124.80 | 2019-2020 | |
| Inari Medical, INC. | $78.96 | 2022 | |
| Cook Medical LLC | $70.58 | 2022 | |
| Organogenesis INC. | $55.39 | 2023 | Puraply |
| Janssen Pharmaceuticals, INC | $49.91 | 2022-2023 | Xarelto |
| Boston Scientific Corporation | $48.47 | 2023 | Eluvia |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $46.10 | 2023 | Vibativ, Caldolor |
| Medline Industries LP | $38.63 | 2022-2023 | |
| Baxter Healthcare | $28.07 | 2023 | Preveleak |
| Tactile Systems Technology INC | $28.02 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Penumbra, INC. | $21.43 | 2023 | Indigo System |
| Kerecis Limited | $21.06 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Ibsa Pharma INC. | $18.99 | 2023 | Tirosint, Licart |
| Davol INC. | $16.17 | 2023 | Avitene Ultrafoam |
| Grt US Holding, INC. | $15.30 | 2021 | |
| Kci USA, INC. | $14.96 | 2023 | Prevena, V.A.C. Veraflo |
| Abbvie INC. | $12.15 | 2022 | |
| Smith+Nephew, INC. | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grady Alsabrook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.